Back

Lipoprotein(a) and cardiovascular–kidney–metabolic syndrome: associations with all-cause mortality and major adverse cardiovascular events in a large population cohort

31 August 2026 (11:15 - 11:25)
Organised by: Logo
Congress Presentation Part of: Risk factors and prevention: biomarkers, inflammation, and cardiac mortality Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Qian Tang

Hangzhou (China)

5 More presentations in this session

Presentation thumbnail
Imaging-derived cardiovascular OrganAge predicts mortality and identifies smoking and diabetes as major accelerators of cardiovascular ageing in UK Biobank
Doctor M. Wamil (Oxford, GB)
Abstract
Presentation thumbnail
Arterial elastance is a heritable and causal vascular endotype of hippocampal atrophy and cognitive decline
Doctor P. Masci (London, GB)
Abstract
Presentation thumbnail
Interleukin-6 predicts cardiovascular events beyond standard modifiable risk factors in individuals without atherosclerotic cardiovascular disease
Mr M. Reugels (Aachen, DE)
Abstract
Presentation thumbnail
Higher hs-CRP predicts severe cardiovascular-kidney-metabolic syndrome stages: The NHANES 2015 – 2018 survey cycle
Doctor D. Corsi (New Brunswick, US)
Abstract
Presentation thumbnail
The impact of inflammatory and cholesterol risk on cardiovascular events among statin-treated individuals: an observational study using UK Biobank data
Doctor D. Niederseer (Davos Wolfgang, CH)
Abstract

Access the full session

Session thumbnail
Risk factors and prevention: biomarkers, inflammation, and cardiac mortality

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular-kidney-metabolic syndrome and association with mortality in the UK Biobank prospective cohort study
1 September 2025
thumbnail
Webinar
Lipoprotein(a): current role and future perspectives in cardiovascular medicine
31 October 2025
thumbnail
Congress Presentation
Association between lipoprotein (a) level and chronic cardio-renal syndrome in patients with coronary artery disease
29 June 2021
thumbnail
Congress Presentation
The association between lipoprotein (a) levels and body composition
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources